Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency.
暂无分享,去创建一个
I. Scheffer | E. Haan | J. Gécz | S. Berkovic | C. Depienne | R. Møller | G. Buchanan | R. Guerrini | C. Shoubridge | M. Corbett | L. Nguyen | C. Marini | L. Sadleir | E. Ranieri | N. Specchio | Raman Kumar | J. Mcmahon | Evelyn Douglas | Chuan Tan | Chloé Shard | K. Hynes | D. Pham | Paul Q. Thomas | Damian Leach | R. Kumar | Duyen H Pham | Grant Buchanan
[1] M. Rogawski,et al. Pediatric super‐refractory status epilepticus treated with allopregnanolone , 2014, Annals of neurology.
[2] Sven Bergmann,et al. A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders. , 2014, American journal of human genetics.
[3] Kyoko Takano,et al. PCDH19-related female-limited epilepsy: Further details regarding early clinical features and therapeutic efficacy , 2013, Epilepsy Research.
[4] M. Rogawski,et al. Neuroactive steroids for the treatment of status epilepticus , 2013, Epilepsia.
[5] A. Cole,et al. SGE‐102: A novel therapy for refractory status epilepticus , 2013, Epilepsia.
[6] N. Akaike,et al. Modulation of allopregnanolone on excitatory transmitters release from single glutamatergic terminal , 2013, Brain Research Bulletin.
[7] A. Kelemen,et al. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders , 2013, neurogenetics.
[8] J. Parsch,et al. The evolutionary causes and consequences of sex-biased gene expression , 2013, Nature Reviews Genetics.
[9] J. Gécz,et al. Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability , 2012, Molecular Psychiatry.
[10] E. Bertini,et al. Somatic mosaicism of PCDH19 mutation in a family with low-penetrance EFMR , 2012, neurogenetics.
[11] P. Dimova,et al. A novel PCDH19 mutation inherited from an unaffected mother. , 2012, Pediatric neurology.
[12] P. Deyn,et al. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model , 2012, Behavioural Brain Research.
[13] H. Shiraishi,et al. PCDH19 mutation in Japanese females with epilepsy , 2012, Epilepsy Research.
[14] F. Vigevano,et al. Acute‐onset epilepsy triggered by fever mimicking FIRES (febrile infection–related epilepsy syndrome): The role of protocadherin 19 (PCDH19) gene mutation , 2011, Epilepsia.
[15] W. Miller,et al. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. , 2011, American journal of human genetics.
[16] Doodipala Samba Reddy,et al. Role of Anticonvulsant and Antiepileptogenic Neurosteroids in the Pathophysiology and Treatment of Epilepsy , 2011, Front. Endocrin..
[17] E. Bertini,et al. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations , 2011, Epilepsia.
[18] C. Harden,et al. Hormonal Therapy for Epilepsy , 2011, Current neurology and neuroscience reports.
[19] C. Depienne,et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy , 2011, Neurology.
[20] M. Avoli,et al. Chapter 7 7 Neurosteroids-Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy , 2017 .
[21] James D. Jontes,et al. Protocadherin-19 and N-cadherin interact to control cell movements during anterior neurulation , 2010, The Journal of cell biology.
[22] H. Vaudry,et al. Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides , 2009, Frontiers in Neuroendocrinology.
[23] M. Rogawski,et al. Neurosteroid replacement therapy for catamenial epilepsy , 2009, Neurotherapeutics.
[24] M. Ruberg,et al. Sporadic Infantile Epileptic Encephalopathy Caused by Mutations in PCDH19 Resembles Dravet Syndrome but Mainly Affects Females , 2009, PLoS genetics.
[25] Yoav Gilad,et al. Sex-specific genetic architecture of human disease , 2008, Nature Reviews Genetics.
[26] Andrew Menzies,et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment , 2008, Nature Genetics.
[27] K. Friend,et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. , 2008, Brain : a journal of neurology.
[28] E. Giller,et al. Clinical Evaluation of Ganaxolone in Pediatric and Adolescent Patients with Refractory Epilepsy , 2007, Epilepsia.
[29] Hui Shen,et al. Neurosteroid regulation of GABAA receptors: Focus on the α4 and δ subunits , 2007 .
[30] J. Gécz,et al. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation , 2007, Nature Genetics.
[31] Trevor M Penning,et al. Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms. , 2007, Archives of biochemistry and biophysics.
[32] M. McCarthy,et al. Focal adhesion kinase and paxillin: novel regulators of brain sexual differentiation? , 2007, Endocrinology.
[33] C. Frye,et al. Seizure exacerbation associated with inhibition of progesterone metabolism , 2003, Annals of neurology.
[34] N. Watson,et al. N-Cadherin expression in motoneurons is directly regulated by androgens: a genetic mosaic analysis in rats , 2001, Brain Research.
[35] B. Bourgeois,et al. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial , 2000, Epilepsy Research.
[36] K. Laxer,et al. Assessment of Ganaxolone's Anticonvulsant Activity Using a Randomized, Double‐Blind, Presurgical Trial Design , 2000, Epilepsia.
[37] L. Pannell,et al. Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. , 1998, The Journal of pharmacology and experimental therapeutics.
[38] P. Klein,et al. Three Patterns of Catamenial Epilepsy , 1997, Epilepsia.
[39] Nancy B. Spinner,et al. Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing , 1997, Nature Genetics.
[40] R. Sparkes,et al. Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization. , 1995, Genomics.
[41] S. Paul,et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.
[42] R. C. Juberg,et al. A new familial form of convulsive disorder and mental retardation limited to females. , 1971, The Journal of pediatrics.
[43] M. Avoli,et al. Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy -- Jasper's Basic Mechanisms of the Epilepsies , 2012 .
[44] Doodipala Samba Reddy,et al. Neurosteroids: endogenous role in the human brain and therapeutic potentials. , 2010, Progress in brain research.